People: Deutsche Lufthansa AG (LHAG.DE)
19 Jun 2019
Dr. Karl-Ludwig Kley has been Independent Chairman of the Supervisory Board of Deutsche Lufthansa Aktiengesellschaft since September 25, 2017. He was Member of the Supervisory Board at Deutsche Lufthansa Aktiengesellschaft from May 7, 2013. He is Chairman of the Audit Committee at the Company since May 7, 2013. Prior to this, he was Chief Financial Officer and Member of the Management Board of Deutsche Lufthansa AG from September 1, 1998 to May 31, 2006. In addition to his duties at the Company, he is Chairman of the Executive Board at Merck KGaA. Dr. Kley was in charge of corporate finance and investor relations at Bayer AG in Leverkusen. Before that, he held a number of senior management positions, which included responsibility for sales and marketing of the company´s Pharmaceuticals division for the regions Africa, Asia and Latin America. During the eight years he spent working in Japan and Italy, Dr. Kley gained management experience in multicultural settings. In addition to his duties within the Lufthansa Group, Dr. Kley is a member of the supervisory boards of Merck KGaA (Darmstadt), Vattenfall Europe (Berlin), Gerling Allgemeine Versicherungs-AG (Cologne), the boards of directors of KG Allgemeine Leasing GmbH & Co. (Gruenwald) and Amadeus Global Travel Distribution SA (Madrid). Dr. Kley is a lawyer by profession. He graduated from Munich University (Ludwig-Maximilians-Universitaet Muenchen) in 1979 and also received his doctorate from that university.
|Total Annual Compensation, EUR||123,000|
|Restricted Stock Award, EUR||--|
|Long-Term Incentive Plans, EUR||--|
|All Other, EUR||45,000|
|Fiscal Year Total, EUR||168,000|